Joe Putnam
Faculty Member
Last active: 3/27/2014

  1. Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Pecot CV, Li M, Zhang XJ, Rajanbabu R, Calitri C, Bungum A, Jett JR, Putnam JB, Callaway-Lane C, Deppen S, Grogan EL, Carbone DP, Worrell JA, Moons KG, Shyr Y, Massion PP (2012) Cancer Epidemiol Biomarkers Prev 21(5): 786-92
    › Primary publication · 22374995 (PubMed) · PMC3660018 (PubMed Central)
  2. Thoracic operations for pulmonary nodules are frequently not futile in patients with benign disease. Grogan EL, Weinstein JJ, Deppen SA, Putnam JB, Nesbitt JC, Lambright ES, Walker RC, Dittus RS, Massion PP (2011) J Thorac Oncol 6(10): 1720-5
    › Primary publication · 21760552 (PubMed) · PMC3712870 (PubMed Central)
  3. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study. Fernando HC, Landreneau RJ, Mandrekar SJ, Hillman SL, Nichols FC, Meyers B, DiPetrillo TA, Heron DE, Jones DR, Daly BD, Starnes SL, Tan A, Putnam JB (2011) J Thorac Cardiovasc Surg 142(5): 1143-51
    › Primary publication · 21872277 (PubMed) · PMC3199353 (PubMed Central)
  4. The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial. Fernando HC, Landreneau RJ, Mandrekar SJ, Hillman SL, Nichols FC, Meyers B, DiPetrillo TA, Heron D, Jones DR, Daly BD, Starnes SL, Hatter JE, Putnam JB (2011) J Thorac Cardiovasc Surg 142(3): 554-62
    › Primary publication · 21724195 (PubMed) · PMC3156868 (PubMed Central)
  5. Successful treatment of atrioesophageal fistula by cervical esophageal ligation and decompression. St Julien J, Putnam JB, Nesbitt JC, Lambright ES, Petracek MR, Grogan EL (2011) Ann Thorac Surg 91(6): e85-6
    › Primary publication · 21619954 (PubMed) · PMC4154501 (PubMed Central)
  6. Resection of pulmonary metastases: a mechanical solution for a biological problem. Putnam JB (2011) Oncology (Williston Park) 25(12): 1206-7
    › Primary publication · 22229213 (PubMed)
  7. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, Jones DR, McKenna RJ, Landreneau RJ, Rusch VW, Putnam JB (2011) J Thorac Cardiovasc Surg 141(3): 662-70
    › Primary publication · 21335122 (PubMed) · PMC5082844 (PubMed Central)
  8. Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. Rusch VW, Hawes D, Decker PA, Martin SE, Abati A, Landreneau RJ, Patterson GA, Inculet RI, Jones DR, Malthaner RA, Cohen RG, Ballman K, Putnam JB, Cote RJ (2011) J Clin Oncol 29(32): 4313-9
    › Primary publication · 21990404 (PubMed) · PMC3221530 (PubMed Central)
  9. Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial. Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, Jones DR, McKenna RJ, Landreneau RJ, Putnam JB (2011) Chest 139(5): 1124-1129
    › Primary publication · 20829340 (PubMed) · PMC3087457 (PubMed Central)
  10. Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Rahman SM, Gonzalez AL, Li M, Seeley EH, Zimmerman LJ, Zhang XJ, Manier ML, Olson SJ, Shah RN, Miller AN, Putnam JB, Miller YE, Franklin WA, Blot WJ, Carbone DP, Shyr Y, Caprioli RM, Massion PP (2011) Cancer Res 71(8): 3009-17
    › Primary publication · 21487035 (PubMed) · PMC3110721 (PubMed Central)